Pharmaceutical care and evaluation of adherence to antiretroviral therapy in people living with HIV/AIDS
Braz. J. Pharm. Sci. (Online)
;
58: e19613, 2022. tab
Artículo
en Inglés
| LILACS
| ID: biblio-1383958
ABSTRACT
Abstract Highly Active Antiretroviral therapy (HAART) depends on optimal adherence to be effective. Pharmacotherapeutic follow-up can be used as a strategy for treatment fidelity. To provide pharmaceutical care for HAART patients, to assess adherence, to identify and resolve drug related problems (DRP). This is a prospective, interventional study aimed at people on HAART. Data was collected using the pharmacotherapeutic follow-up form and CEAT-VIH. There was a predominance of women (59%), older than 33 years (75%), mostly single (43%). Regarding adherence, 64% had insufficient adherence at the start of the study, while 36% had strict/adequate adherence. After the pharmacotherapeutic follow-up, 70% presented strict/adequate adherence. Regarding HAART, the relationship between adhesion versus time of HAART and adherence versus regimen used was significant, considering that less time of therapy and regimen containing protease inhibitors are predictors for insufficient adherence. Regarding the DRP identified (f=77), missed pills (32%), untreated disease, incorrect management frequency, and undue self-medication (12%) were the most frequent. Pharmaceutical interventions (f=137) were predominantly advising related to specific pharmacological treatment (32%), non-pharmacological measures (20%), and medication suspension (9%). Pharmaceutical care was shown to be animportant strategy, within the multi professional team, to improve adherence, besides identifying and resolving DRP.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Servicios Farmacéuticos
/
Síndrome de Inmunodeficiencia Adquirida
/
VIH
/
Terapia Antirretroviral Altamente Activa
/
Cumplimiento y Adherencia al Tratamiento
Límite:
Adulto
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Braz. J. Pharm. Sci. (Online)
Asunto de la revista:
Farmacologia
/
Teraputica
/
Toxicologia
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Federal University of Rio Grande do Sul/BR
/
State Secretary of Health - SESA/BR
/
State University of Maringá/BR
/
State University of Paraná/BR
Similares
MEDLINE
...
LILACS
LIS